Compare BYSI & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BYSI | TVGN |
|---|---|---|
| Founded | 2010 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.9M | 63.9M |
| IPO Year | 2016 | N/A |
| Metric | BYSI | TVGN |
|---|---|---|
| Price | $1.61 | $4.76 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.3K | ★ 368.0K |
| Earning Date | 03-25-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.98 | $0.14 |
| 52 Week High | $3.44 | $10.76 |
| Indicator | BYSI | TVGN |
|---|---|---|
| Relative Strength Index (RSI) | 51.88 | 59.14 |
| Support Level | $1.38 | $0.53 |
| Resistance Level | $1.83 | $10.76 |
| Average True Range (ATR) | 0.15 | 0.73 |
| MACD | 0.00 | -0.18 |
| Stochastic Oscillator | 48.98 | 2.53 |
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.